KP
KIORA PHARMACEUTICALS INC
SEC filingPharmaceuticals · Encinitas, CA
Amount raised$5Msold at filing
Total offering$5M
Investors in the raise3count reported to the SEC
FiledApr 21, 2026first sale Apr 6, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Lisa Walters-HoffertDirector
David HollanderDirector
Praveen TyleDirector
Brian StremExecutive Officer
Melissa ToscaExecutive Officer
Carmine StengoneDirector
Erin ParsonsDirector
Aron ShapiroDirector
Executive officers, directors and promoters as listed on the Form D.